VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $207,501 | -8.6% | 6,891 | -1.8% | 0.02% | -11.8% |
| Q1 2023 | $226,917 | -22.0% | 7,014 | -30.9% | 0.02% | -39.3% |
| Q4 2022 | $290,739 | +12.3% | 10,144 | -5.7% | 0.03% | +3.7% |
| Q3 2022 | $259,000 | -61.3% | 10,761 | -56.0% | 0.03% | -57.1% |
| Q2 2022 | $669,000 | -40.0% | 24,446 | -16.0% | 0.06% | -33.0% |
| Q1 2022 | $1,115,000 | -18.1% | 29,096 | -31.6% | 0.09% | -18.3% |
| Q4 2021 | $1,362,000 | +1.3% | 42,527 | -6.8% | 0.12% | -24.3% |
| Q3 2021 | $1,344,000 | -18.3% | 45,612 | -5.9% | 0.15% | -23.2% |
| Q2 2021 | $1,646,000 | +6.4% | 48,454 | +1.7% | 0.20% | -19.8% |
| Q1 2021 | $1,547,000 | +32.3% | 47,625 | +46.6% | 0.25% | +1.2% |
| Q4 2020 | $1,169,000 | +30.6% | 32,477 | +42.1% | 0.24% | +10.9% |
| Q3 2020 | $895,000 | +8.6% | 22,863 | +1.7% | 0.22% | -7.6% |
| Q2 2020 | $824,000 | – | 22,485 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |